[Epstein-Barr virus and oncogenesis].
Sairenji
Takeshi
T
Devision of Biosignaling, Department of Biomedical Sciences, School of Life Science, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503.
D017209:Apoptosis; D001402:B-Lymphocytes / Q000166:cytology / Q000821:virology; D002455:Cell Division; D020031:Epstein-Barr Virus Infections / Q000821:virology*; D019309:Epstein-Barr Virus Nuclear Antigens / Q000502:physiology; D005814:Genes, Viral / Q000502:physiology; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000473:pathology / Q000821:virology*; D016601:RNA-Binding Proteins / Q000502:physiology; D012269:Ribosomal Proteins; D015398:Signal Transduction; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000502:physiology; D053773:Transforming Growth Factor beta1; D014763:Viral Matrix Proteins / Q000502:physiology; D014779:Virus Replication
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019309:Epstein-Barr Virus Nuclear Antigens; D016601:RNA-Binding Proteins; D012269:Ribosomal Proteins; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D014763:Viral Matrix Proteins; C067169:RPL22 protein, human; C417029:EBV-encoded nuclear antigen 1